Welcome to your 4. 🦵 Osteoarthritis & Gout Arena — 40 Integrated MCQs
1.
Which statement best differentiates the overall treatment strategy of osteoarthritis from that of gout?
2.
A woman with knee osteoarthritis asks why physiotherapy remains important even though pain medication has already improved her symptoms. What is the best explanation?
3.
A patient with recurrent gout has persistent hyperuricemia despite lifestyle changes. He asks whether dietary modification alone is sufficient. Which principle is most appropriate?
4.
A patient with severe hip osteoarthritis continues to have disabling pain and marked functional limitation despite appropriate conservative management. Which management option should now be considered?
5.
A 60-year-old man with recurrent gout and a previous uric acid renal stone is being assessed for long-term treatment. Which class of urate-lowering drug would be less attractive because it increases urinary urate excretion?
6.
A 57-year-old man with acute gout has a history of peptic ulcer disease and significant renal impairment. Which therapeutic approach is a reasonable alternative when NSAIDs and colchicine are unsuitable?
7.
A 70-year-old woman with knee osteoarthritis gradually becomes less active because of pain. Several months later, walking becomes even more difficult despite no major radiographic progression. Which mechanism best explains this deterioration?
8.
A 66-year-old man with advanced hip osteoarthritis has severe pain at rest, major limitation of walking and failure of appropriate non-operative treatment. Which feature most strongly supports referral for joint replacement?
9.
A 65-year-old woman with localized knee osteoarthritis requires additional pain relief. Which treatment provides anti-inflammatory benefit with relatively limited systemic exposure?
10.
A patient with acute gout has no contraindication to anti-inflammatory therapy. Which drug class can provide rapid symptomatic control during the attack?
11.
A patient with recurrent gout requires long-term urate-lowering treatment. Which drug reduces uric acid production by inhibiting xanthine oxidase?
12.
Which renal complication may occur in a patient with long-standing hyperuricemia and gout?
13.
A 59-year-old overweight man with knee osteoarthritis avoids walking because he believes movement will further damage his joint. His quadriceps strength is declining. Which advice is most appropriate?
14.
A patient with knee osteoarthritis has weak quadriceps muscles and increasing difficulty while climbing stairs. Which intervention most directly helps improve joint support?
15.
A patient presents within several hours of onset of an acute gout attack. What is the main immediate treatment objective?
16.
A patient with recurrent gout asks why long-term treatment is continued even when he has no current joint pain. Which explanation is most appropriate?
17.
A 64-year-old woman with knee osteoarthritis has pain while walking and difficulty performing daily activities. Radiographs show marked degenerative changes, but she prefers conservative management. Which factor should most strongly guide escalation of her treatment?
18.
Which statement best describes the role of allopurinol in a patient with gout?
19.
A patient with poorly controlled recurrent gout develops persistent joint pain and deformity. Which complication best explains this progression?
20.
A 55-year-old man presents with a hot, red, acutely swollen knee and severe pain. He has previously been diagnosed with gout. Which alternative diagnosis remains especially important to consider?
21.
A 58-year-old man with known gout presents with fever, severe knee pain, marked swelling and inability to move the joint. The current episode is more severe than his previous attacks. What is the most appropriate clinical approach?
22.
A 52-year-old man presents 8 hours after the onset of severe gouty pain in the ankle. There is marked swelling and tenderness. Why is early anti-inflammatory therapy useful?
23.
A 58-year-old man develops sudden severe pain, redness and swelling of the first metatarsophalangeal joint. Which substance is responsible for the characteristic crystal deposition in gout?
24.
A patient with osteoarthritis asks what the main limitation of analgesic treatment is. Which response is most accurate?
25.
Which abnormality most directly promotes formation of monosodium urate crystals in gout?
26.
Two patients have chronic joint disease. Patient X has gradually progressive knee pain with activity and loss of mobility. Patient Y has recurrent abrupt attacks of intensely inflamed joints associated with hyperuricemia. Which management pairing best reflects the different underlying processes?
27.
Colchicine reduces inflammation in acute gout mainly by interfering with which cellular process?
28.
A man with recurrent gout has been taking allopurinol but develops an adverse reaction requiring discontinuation. Which drug acts through a similar urate-lowering principle and may be considered as an alternative in selected patients?
29.
A patient with osteoarthritis is started on an oral NSAID for persistent pain. Which clinical factor is particularly important when assessing the safety of this treatment?
30.
A 67-year-old overweight man has symptomatic knee osteoarthritis. Which non-pharmacological measure is most important for reducing mechanical stress on the affected joint?
31.
A patient with advanced osteoarthritis gradually reduces physical activity because of chronic joint pain. Which complication may develop as a direct consequence of reduced joint use?
32.
A 62-year-old woman has chronic knee pain that worsens while walking and improves with rest. Which underlying process best explains her osteoarthritis?
33.
Which complication results from long-standing deposition of monosodium urate crystals in soft tissues?
34.
A patient with an acute gout attack cannot take an NSAID because of significant gastrointestinal disease. Which treatment is an appropriate anti-inflammatory alternative?
35.
A 63-year-old man with poorly controlled gout develops firm nodular deposits around the fingers and reduced joint movement. Which process most directly explains these findings?
36.
A patient has recurrent gout despite modification of contributing factors. What is the main purpose of long-term urate-lowering therapy?
37.
A patient with acute gout has moderate chronic kidney disease and is being considered for colchicine treatment. Which issue is most important when using this drug?
38.
A 71-year-old woman with symptomatic knee osteoarthritis has chronic kidney disease and a previous peptic ulcer. She requires additional local pain control. Which option is most appropriate before considering regular systemic NSAID therapy?
39.
A patient with knee osteoarthritis has a temporary marked increase in pain despite appropriate exercise and simple measures. There is no evidence of infection. Which intervention may provide short-term relief directly within the affected joint?
40.
A 68-year-old man with hip osteoarthritis has an antalgic gait and pain during prolonged walking. Which supportive intervention can reduce mechanical loading of the affected joint while maintaining mobility?
